SCHEMBL32663569

SCHEMBL32663569

CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4cnc(NC5CCN(C6CC6)CC5)c(Cl)c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 18/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1700129 1.00 BCL2 (1.00) BCL2
SCHEMBL1701763 0.92 BCL2 (1.00) BCL2
SCHEMBL30314149 0.92 BCL2 (1.00) BCL2
SCHEMBL1701435 0.91 BCL2 (1.00) BCL2
SCHEMBL30313987 0.91 BCL2 (1.00) BCL2
SCHEMBL1701558 0.90 BCL2 (1.00) BCL2
SCHEMBL1700269 0.90 BCL2 (1.00) BCL2
SCHEMBL30314193 0.90 BCL2 (1.00) BCL2
SCHEMBL1701589 0.89 BCL2 (1.00) BCL2
SCHEMBL31344637 0.89 BCL2 (1.00) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4682148-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES AbbVie Ireland Unlimited Company (IE) 2026-01-21 — — EP disclosed
Send feedback